FDA Inspection 903523 — Halo Pharmaceutical Canada Inc
The FDA completed an inspection of Halo Pharmaceutical Canada Inc on November 14, 2014 in Mirabel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 14, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mirabel (Canada)